Back to results
US 10,471,067 B2Granted
Nanoparticulate meloxicam formulations
AssigneeRecro Pharma, Inc.
InventorsEugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
Life of this patent
Estimating the term…
Abstract
The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
Claims8
An injectable pharmaceutical dosage form comprising:
- 30 mg of meloxicam, or a salt thereof, wherein the meloxicam is in the form of particles having an effective average particle size of less than or about 2000 nm;
- polyvinylpyrrolidone;
- sodium deoxycholate;
- sucrose;
- and
- water;
- wherein the dosage form does not comprise a combination of meloxicam and a vasomodulator.
4 more elements
An injectable pharmaceutical dosage form consisting essentially of:
- 30 mg of meloxicam, or a salt thereof, wherein the meloxicam is in the form of particles having an effective average particle size of less than about 400 nm;
- polyvinylpyrrolidone;
- sodium deoxycholate;
- sucrose;
- and
- water.
3 more elements
Dependencies are inferred from the claim text.